News & Analysis on Clinical Trial Services & Contract Research And Development
Nanogen has been issued with a European patent, which relates to a nanofabrication technology combining a manufacturing platform and nanostructures that is set to broaden Nanogen's position in the nanotechnology and nanomanufacturing areas.
BioGenex announces the launch of the Xmatrx, a walk-away system that automates molecular diagnostics and drug target identification and validation. The system is specifically designed to enable drug discovery companies to customise applications with...
Antares Pharma has announced that it has completed formulation and preclinical activities for its first fast melt oral tablet incorporating a nonsteroidal anti-inflammatory drug (NSAID) using its Easy Tec fast melt technology.
The Danish NovoSeven Facility has been given the '2005 Facility of the Year Award' by the foremost representatives of the pharmaceutical industry's international engineering society.